Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ABLATUS THERAPEUTICS LIMITED

Company number 09812865

Follow this company File for this company

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 May 2021 SH01 Statement of capital following an allotment of shares on 13 April 2021
  • GBP 30.90898
10 May 2021 SH01 Statement of capital following an allotment of shares on 8 September 2020
  • GBP 27.08007
23 Mar 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 24 April 2020
  • GBP 26.88629
19 Jan 2021 SH01 Statement of capital following an allotment of shares on 22 December 2020
  • GBP 30.46574
09 Jan 2021 AA Accounts for a small company made up to 31 December 2019
23 Nov 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
16 Nov 2020 SH01 Statement of capital following an allotment of shares on 11 November 2020
  • GBP 30.02582
16 Nov 2020 CS01 Confirmation statement made on 6 October 2020 with updates
12 Nov 2020 PSC02 Notification of Mercia Asset Management Plc as a person with significant control on 3 December 2019
12 Nov 2020 PSC07 Cessation of Nvm Private Equity Llp as a person with significant control on 2 December 2019
01 Jul 2020 TM01 Termination of appointment of David Graham Brooks as a director on 30 June 2020
10 Jun 2020 SH01 Statement of capital following an allotment of shares on 17 April 2020
  • GBP 27.08007
  • ANNOTATION Clarification a second filed SH01 was registered on 23/03/2021
22 Apr 2020 AP01 Appointment of Dr Natalie Jayne Hayes as a director on 17 April 2020
21 Apr 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
03 Apr 2020 SH01 Statement of capital following an allotment of shares on 26 March 2020
  • GBP 26.07617
15 Oct 2019 CS01 Confirmation statement made on 6 October 2019 with no updates
15 May 2019 AA Accounts for a small company made up to 31 December 2018
19 Oct 2018 CS01 Confirmation statement made on 6 October 2018 with updates
19 Oct 2018 PSC02 Notification of Nvm Private Equity Llp as a person with significant control on 19 April 2018
04 Sep 2018 SH01 Statement of capital following an allotment of shares on 10 August 2018
  • GBP 24.52579
03 Sep 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
30 Jul 2018 RP04SH01 Second filing of a statement of capital following an allotment of shares on 19 April 2018
  • GBP 23.89532
25 Jun 2018 AA Accounts for a small company made up to 31 December 2017
14 Jun 2018 AD01 Registered office address changed from 1 st James Court Whitefriars Norwich Norfolk NR3 1RU United Kingdom to 30 Broad Street Great Cambourne Cambridge CB23 6HJ on 14 June 2018
17 May 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association